Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
Add more filters










Publication year range
1.
Brain Stimul ; 12(5): 1151-1158, 2019.
Article in English | MEDLINE | ID: mdl-31129152

ABSTRACT

BACKGROUND: Electrical stimulation on select areas of the external auricular dermatome influences the autonomic nervous system. It has been postulated that activation of the Auricular Branch of the Vagus Nerve (ABVN) mediates such autonomic changes. However, the underlying neural pathways mediating these effects are unknown and, further, our understanding of the anatomical distribution of the ABVN in the auricle has now been questioned. OBJECTIVE: To investigate the effects of electrical stimulation of the tragus on autonomic outputs in the rat and probe the underlying neural pathways. METHODS: Central neuronal projections from nerves innervating the external auricle were investigated by injections of the transganglionic tracer cholera toxin B chain (CTB) into the right tragus of Wistar rats. Physiological recordings of heart rate, perfusion pressure, respiratory rate and sympathetic nerve activity were made in an anaesthetic free Working Heart Brainstem Preparation (WHBP) of the rat and changes in response to electrical stimulation of the tragus analysed. RESULTS: Neuronal tracing from the tragus revealed that the densest CTB labelling was within laminae III-IV of the dorsal horn of the upper cervical spinal cord, ipsilateral to the injection sites. In the medulla oblongata, CTB labelled afferents were observed in the paratrigeminal nucleus, spinal trigeminal tract and cuneate nucleus. Surprisingly, only sparse labelling was observed in the vagal afferent termination site, the nucleus tractus solitarius. Recordings made from rats at night time revealed more robust sympathetic activity in comparison to day time rats, thus subsequent experiments were conducted in rats at night time. Electrical stimulation was delivered across the tragus for 5 min. Direct recording from the sympathetic chain revealed a central sympathoinhibition by up to 36% following tragus stimulation. Sympathoinhibition remained following sectioning of the cervical vagus nerve ipsilateral to the stimulation site, but was attenuated by sectioning of the upper cervical afferent nerve roots. CONCLUSIONS: Inhibition of the sympathetic nervous system activity upon electrical stimulation of the tragus in the rat is mediated at least in part through sensory afferent projections to the upper cervical spinal cord. This challenges the notion that tragal stimulation is mediated by the auricular branch of the vagus nerve and suggests that alternative mechanisms may be involved.


Subject(s)
Cervical Vertebrae , Heart Rate/physiology , Sensory Receptor Cells/physiology , Spinal Cord/physiology , Transcutaneous Electric Nerve Stimulation/methods , Vagus Nerve/physiology , Afferent Pathways/physiology , Animals , Brain Stem/physiology , Male , Organ Culture Techniques , Rats , Rats, Wistar , Solitary Nucleus/physiology , Vagus Nerve Stimulation/methods
2.
Brain Struct Funct ; 220(3): 1421-36, 2015.
Article in English | MEDLINE | ID: mdl-24595534

ABSTRACT

Sensory information arising from the upper neck is important in the reflex control of posture and eye position. It has also been linked to the autonomic control of the cardiovascular and respiratory systems. Whiplash associated disorders (WAD) and cervical dystonia, which involve disturbance to the neck region, can often present with abnormalities to the oromotor, respiratory and cardiovascular systems. We investigated the potential neural pathways underlying such symptoms. Simulating neck afferent activity by electrical stimulation of the second cervical nerve in a working heart brainstem preparation (WHBP) altered the pattern of central respiratory drive and increased perfusion pressure. Tracing central targets of these sensory afferents revealed projections to the intermedius nucleus of the medulla (InM). These anterogradely labelled afferents co-localised with parvalbumin and vesicular glutamate transporter 1 indicating that they are proprioceptive. Anterograde tracing from the InM identified projections to brain regions involved in respiratory, cardiovascular, postural and oro-facial behaviours--the neighbouring hypoglossal nucleus, facial and motor trigeminal nuclei, parabrachial nuclei, rostral and caudal ventrolateral medulla and nucleus ambiguus. In brain slices, electrical stimulation of afferent fibre tracts lateral to the cuneate nucleus monosynaptically excited InM neurones. Direct stimulation of the InM in the WHBP mimicked the response of second cervical nerve stimulation. These results provide evidence of pathways linking upper cervical sensory afferents with CNS areas involved in autonomic and oromotor control, via the InM. Disruption of these neuronal pathways could, therefore, explain the dysphagic and cardiorespiratory abnormalities which may accompany cervical dystonia and WAD.


Subject(s)
Cardiovascular Physiological Phenomena , Medulla Oblongata/physiology , Medulla Oblongata/ultrastructure , Neck Muscles/innervation , Neck Muscles/physiology , Respiration , Afferent Pathways/physiology , Animals , Brain Stem/physiology , Brain Stem/ultrastructure , Cardiovascular System/innervation , Electric Stimulation , Hypoglossal Nerve/physiology , Male , Mice , Neck Muscles/cytology , Neurons/metabolism , Neurons/physiology , Neurons/ultrastructure , Phrenic Nerve/physiology , Rats, Wistar , Vesicular Glutamate Transport Protein 1/metabolism
3.
Brain Struct Funct ; 218(3): 751-65, 2013 May.
Article in English | MEDLINE | ID: mdl-22638825

ABSTRACT

Connexin (Cx) proteins localized to neuronal and glial syncytia provide the ultrastructural components for intercellular communication via gap junctions. In this study, a Cx45 reporter mouse model in which the Cx45 coding sequence is substituted for enhanced green fluorescent protein (eGFP) was used to characterize Cx45 expressing neurones within adult mouse spinal cord. eGFP-immunoreactive (eGFP-IR) cells were localized at all rostro-caudal levels to laminae I-III of the dorsal horn (DH), areas associated with nociception. The neuronal rather than glial phenotype of these cells in DH was confirmed by co-localisation of eGFP-IR with the neuronal marker NeuN. Further immunohistochemical studies revealed that eGFP-IR interneurones co-express the calcium-binding protein calbindin, and to a lesser extent calretinin. In contrast, eGFP-IR profiles did not co-localize with either parvalbumin or GAD-67, both of which are linked to inhibitory interneurones. Staining with the primary afferent markers isolectin-B4 (IB4) and calcitonin gene-related peptide revealed that eGFP-IR somata within laminae I-III receive close appositions from the former, presumed non-peptidergic nociceptive afferents of peripheral origin. The presence of 5-HT terminals in close apposition to eGFP-IR interneuronal somata suggests modulation via descending pathways. These data demonstrate a highly localized expression of Cx45 in a population of interneurones within the mouse superficial dorsal horn. The implications of these data in the context of the putative role of Cx45 and gap junctions in spinal somatosensory processing and pain are discussed.


Subject(s)
Connexins/genetics , Connexins/metabolism , Gene Expression Regulation/genetics , Posterior Horn Cells/metabolism , Spinal Cord/cytology , Animals , Choline O-Acetyltransferase/metabolism , Glutamate Decarboxylase/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Mice , Mice, Transgenic , Nerve Tissue Proteins/metabolism , Receptors, Opioid, mu , Serotonin/metabolism
4.
Neuroscience ; 170(3): 827-38, 2010 Oct 27.
Article in English | MEDLINE | ID: mdl-20650307

ABSTRACT

Neuronal networks generating rhythmic activity as an emergent property are common throughout the nervous system. Some are responsible for rhythmic behaviours, as is the case for the spinal cord locomotor networks; however, for others the function is more subtle and usually involves information processing and/or transfer. An example of the latter is sympathetic nerve activity, which is synchronized into rhythmic bursts in vivo. This arrangement is postulated to offer improved control of target organ responses compared to tonic nerve activity. Traditionally, oscillogenic circuits in the brainstem are credited with generating these rhythms, despite evidence for the persistence of some frequencies in spinalized preparations. Here, we show that rhythmic population activity can be recorded from the intermediolateral cell column (IML) of thoracic spinal cord slices. Recorded in slices from 10- to 12-day-old rats, this activity was manifest as 8-22 Hz oscillations in the field potential and was spatially restricted to the IML. Oscillations often occurred spontaneously, but could also be induced by application of 5-HT, α-methyl 5-HT or MK212. These agents also significantly increased the strength of spontaneous oscillations. Rhythmic activity was abolished by TTX and attenuated by application of gap junction blockers or by antagonists of GABA(A) receptors. Together these data indicate that this rhythm is an emergent feature of a population of spinal neurons coupled by gap junctions. This work questions the assumption that sympathetic rhythms are dependent on supraspinal pacemaker circuits, by highlighting a surprisingly strong rhythmogenic capability of the reduced sympathetic networks of the spinal cord slice.


Subject(s)
Adrenergic Fibers/physiology , Autonomic Fibers, Preganglionic/physiology , Periodicity , Spinal Cord/physiology , Action Potentials/drug effects , Action Potentials/physiology , Adrenergic Fibers/drug effects , Animals , Autonomic Fibers, Preganglionic/drug effects , Bicuculline/pharmacology , Female , Male , Pyrazines/pharmacology , Rats , Rats, Wistar , Serotonin/analogs & derivatives , Serotonin/pharmacology , Spinal Cord/drug effects , Tetrodotoxin/pharmacology
5.
Auton Neurosci ; 126-127: 193-201, 2006 Jun 30.
Article in English | MEDLINE | ID: mdl-16580888

ABSTRACT

We previously identified an action of nitric oxide (NO) within the nucleus tractus solitarii (NTS) that attenuates the cardiac component of the baroreceptor reflex. In the present study we have tested the hypothesis that angiotensin II (AngII), acting on angiotensin type 1 receptors (AT1R), can release NO within the NTS and that its actions are mediated by soluble guanylate cyclase (sGC). Utilising cryogenic electron paramagnetic resonance (EPR), we have detected NO release in brainstem samples following AngII, but not saline, microinjections into the NTS. In these experiments, we confirmed that both AngII and a NO donor (diethylamine NONOate) in the NTS both depressed the baroreflex bradycardia. In additional studies, we showed that the latter effects were both sensitive to blockade of sGC using 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ). To initiate studies to resolve the cellular source of NO released by angiotensin II in the NTS, we performed immunohistochemical/electron microscopy studies on the distribution of AT1R. We found AT1R located on NTS neurones and blood vessels. Since a rise in intracellular calcium [Ca]i levels is prerequisite for nNOS activation, we imaged responses in [Ca]i in NTS neurones during exposure to AngII in vitro using confocal microscopy. Our data indicate a paucity of neurones showing changes in [Ca]i when exposed to AngII (200 nM). We suggest that AngII-induced release of NO is from non-neuronal sites. With the presence of AT1R on blood vessel endothelial cells we propose that AngII released NO in the NTS is due to activation of endothelial nitric oxide synthase located within the endothelium. The present study supports the novel concept that AngII can trigger NO release in the NTS by a mechanism of vascular-neuronal signalling that affects central neuronal networks regulating cardiovascular function.


Subject(s)
Angiotensin II/pharmacology , Nitric Oxide/metabolism , Solitary Nucleus/drug effects , Solitary Nucleus/enzymology , Animals , Baroreflex/drug effects , Drug Interactions , Electron Spin Resonance Spectroscopy/methods , Guanylate Cyclase/antagonists & inhibitors , Guanylate Cyclase/pharmacology , Hydrazines/pharmacology , Immunohistochemistry/methods , In Vitro Techniques , Male , Microscopy, Immunoelectron/methods , Nitric Oxide Donors/pharmacology , Nitrogen Oxides/pharmacology , Oxadiazoles/pharmacology , Rats , Rats, Wistar , Receptor, Angiotensin, Type 1/metabolism , Receptor, Angiotensin, Type 1/ultrastructure , Solitary Nucleus/metabolism , Solitary Nucleus/ultrastructure
6.
Neuroscience ; 135(1): 133-45, 2005.
Article in English | MEDLINE | ID: mdl-16084661

ABSTRACT

The central projections and neurochemistry of vagal afferent neurones supplying the heart in the rat were investigated by injecting cholera toxin B-subunit into the pericardium. Transganglionically transported cholera toxin B-subunit was visualized in the medulla oblongata in axons and varicosities that were predominantly aggregated in the dorsomedial, dorsolateral, ventrolateral and commissural subnuclei of the caudal nucleus of the solitary tract. Unilateral vagal section in control rats prevented cholera toxin B-subunit labeling on the ipsilateral side of the nucleus of the solitary tract. Fluorescent and electron microscopic dual labeling showed colocalization of immunoreactivity for vesicular glutamate transporter 1, but only rarely vesicular glutamate transporters 2 or 3 with cholera toxin B-subunit in terminals in nucleus of the solitary tract, suggesting that cardiac vagal axons release glutamate as a neurotransmitter. In contrast, populations of vagal afferent fibers labeled by injection of cholera toxin B-subunit, tetra-methylrhodamine dextran or biotin dextran amine into the aortic nerve, stomach or nodose ganglion colocalized vesicular glutamate transporter 2 more frequently than vesicular glutamate transporter 1. The presence of other neurochemical markers of primary afferent neurones was examined in nucleus of the solitary tract axons and nodose ganglion cells labeled by pericardial cholera toxin B-subunit injections. Immunoreactivity for a 200-kDa neurofilament protein in many large, cholera toxin B-subunit-labeled nodose ganglion cells indicated that the cardiac afferent fibers labeled are mostly myelinated, whereas binding of Griffonia simplicifolia isolectin B4 to fewer small cholera toxin B-subunit-labeled ganglion cells suggested that tracer was also taken up by some non-myelinated axons. A few labeled nucleus of the solitary tract axons and ganglion cells were positive for substance P and calcitonin gene-related peptide, which are considered as peptide markers of nociceptive afferent neurones. These data suggest that the population of cardiac vagal afferents labeled by pericardial cholera toxin B-subunit injection is neurochemically varied, which may be related to a functional heterogeneity of baroreceptive, chemoreceptive and nociceptive afferent fibers. A high proportion of cardiac neurones appear to be glutamatergic, but differ from other vagal afferents in expressing vesicular glutamate transporter 1.


Subject(s)
Heart/innervation , Neurons, Afferent/physiology , Presynaptic Terminals/physiology , Solitary Nucleus/physiology , Vagus Nerve/physiology , Vesicular Glutamate Transport Protein 1/biosynthesis , Animals , Aorta, Thoracic/innervation , Aorta, Thoracic/metabolism , Biomarkers , Biotin/analogs & derivatives , Dextrans , Fluorescent Antibody Technique , Fluorescent Dyes , Gastric Mucosa/metabolism , Image Processing, Computer-Assisted , Male , Medulla Oblongata/cytology , Medulla Oblongata/physiology , Microscopy, Electron , Nerve Fibers/metabolism , Neural Pathways/cytology , Neural Pathways/metabolism , Nodose Ganglion/cytology , Nodose Ganglion/physiology , Pericardium/cytology , Pericardium/innervation , Pericardium/metabolism , Rats , Rats, Wistar , Solitary Nucleus/cytology , Stomach/innervation , Tissue Fixation , Vagus Nerve/cytology
7.
Brain Res ; 1034(1-2): 40-50, 2005 Feb 09.
Article in English | MEDLINE | ID: mdl-15713258

ABSTRACT

Adenosine triphosphate is released into the synaptic cleft of the neuromuscular junction during normal synaptic transmission, and in much greater quantities following injury and ischaemia. There is much data to suggest roles for presynaptic P2 receptors but little to demonstrate which specific receptor subunits are present. Here we show P2X7 receptor subunits on presynaptic motor nerve terminals from birth, but no evidence for P2X1, P2X2, P2X3, P2X4, P2X5 or P2X6 receptor subunits. Further, P2X receptor subunits are present as multimeric, membrane-inserted receptors. A selective agonist, 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP: 100 microM), triggers vesicle release from motor nerve terminals, which is blocked by P2X7RS-specific concentrations of periodate oxidised ATP (OxATP: 100 microM) and brilliant blue G (BBG: 1 microM), but not by suramin (100 microM). Vesicle release is enhanced in the absence of extracellular divalent cations and occurs through activation of the ion channel and not any associated large pore, as we failed to label nerve terminals with large membrane-impermeant molecules after addition of BzATP. We conclude that a P2X7-like receptor is present at mouse motor nerve terminals, and that their activation promotes vesicle release.


Subject(s)
Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/metabolism , Motor Neurons/metabolism , Muscle, Skeletal/innervation , Neuromuscular Junction/metabolism , Receptors, Purinergic P2/metabolism , Synaptic Transmission/physiology , Adenosine Triphosphate/pharmacology , Animals , Benzenesulfonates/pharmacology , Cations, Divalent/metabolism , Ion Channels/drug effects , Ion Channels/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission , Motor Neurons/drug effects , Motor Neurons/ultrastructure , Neuromuscular Junction/drug effects , Neuromuscular Junction/ultrastructure , Platelet Aggregation Inhibitors/pharmacology , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Protein Subunits/metabolism , Purinergic P2 Receptor Agonists , Purinergic P2 Receptor Antagonists , Receptors, Purinergic P2X7 , Synaptic Membranes/drug effects , Synaptic Membranes/metabolism , Synaptic Membranes/ultrastructure , Synaptic Transmission/drug effects , Synaptic Vesicles/drug effects , Synaptic Vesicles/metabolism , Synaptic Vesicles/ultrastructure , Time Factors
8.
Neuroscience ; 126(4): 1001-10, 2004.
Article in English | MEDLINE | ID: mdl-15207333

ABSTRACT

Voltage-gated K+ channels (Kv) are divided into eight subfamilies (Kv1-8) and play a major role in determining the excitability of neurones. Members of the Kv3 subfamily are highly abundant in the CNS, with each Kv3 gene (Kv3.1-Kv3.4) exhibiting a unique pattern of expression, although single neurones can express more than one subtype. Of the Kv3 subunits relatively little is known of the Kv3.4 subunit distribution in the nervous system, particularly in the brainstem and spinal cord of the rat. We performed immunohistochemistry to determine both the cellular and sub-cellular distribution of the Kv3.4 subunit in these areas. Kv3.4 subunit immunoreactivity (Kv3.4-IR) was widespread, with dense, punctate staining in many regions including the intermediolateral cell column (IML) and the dorsal vagal nucleus (DVN), nucleus ambiguus (NA) and nucleus tractus solitarius (NTS). In the ventral horn a presynaptic location was confirmed by co-localization of Kv3.4-IR with the synaptic vesicle protein, SV2 and also with the glutamate vesicle markers vesicular glutamate transporter (VGluT) 1, VGluT2 or the glycine transporter GlyT2, suggesting a role for the channel in both excitatory and inhibitory neurotransmission. Electron microscopy confirmed a presynaptic terminal location of Kv3.4-IR in the VH, IML, DVN, NA and NTS. Interestingly however, patches of Kv3.4-IR were also revealed postsynaptically in dendritic and somatic structures throughout these areas. This staining was striking due to its localization at synaptic junctions at terminals with morphological features consistent with excitatory functions, suggesting an association with the postsynaptic density. Therefore the pre and postsynaptic localization of Kv3.4-IR suggests a role both in the control of transmitter release and in regulating neuronal excitability.


Subject(s)
Brain Stem/metabolism , Dendrites/metabolism , Membrane Transport Proteins , Potassium Channels, Voltage-Gated , Potassium Channels/metabolism , Presynaptic Terminals/metabolism , Spinal Cord/metabolism , Vesicular Transport Proteins , Amino Acid Transport Systems, Neutral/metabolism , Animals , Brain Stem/ultrastructure , Carrier Proteins/metabolism , Dendrites/ultrastructure , Glycine Plasma Membrane Transport Proteins , Humans , Immunohistochemistry/methods , Membrane Glycoproteins/metabolism , Microscopy, Immunoelectron/methods , Nerve Tissue Proteins/metabolism , Presynaptic Terminals/ultrastructure , Rats , Rats, Wistar , Shaw Potassium Channels , Spinal Cord/ultrastructure , Synapses/metabolism , Synapses/ultrastructure , Vesicular Glutamate Transport Protein 1 , Vesicular Glutamate Transport Protein 2
9.
Neuroscience ; 123(3): 761-8, 2004.
Article in English | MEDLINE | ID: mdl-14706788

ABSTRACT

Presynaptic P2X(7) receptors are thought to play a role in the modulation of transmitter release and have been localised to terminals with the location and morphology typical of excitatory boutons. To test the hypothesis that this receptor is preferentially associated with excitatory terminals we combined immunohistochemistry for the P2X(7) receptor subunit (P2X(7)R) with that for two vesicular glutamate transporters (VGLUT1 and VGLUT2) in the rat CNS. This confirmed that P2X(7)R immunoreactivity (IR) is present in glutamatergic terminals; however, whether it was co-localised with VGLUT1-IR or VGLUT2-IR depended on the CNS region examined. In the spinal cord, P2X(7)R-IR co-localised with VGLUT2-IR. In the brainstem, co-localisation of P2X(7)R-IR with VGLUT2-IR was widespread, but co-localisation with VGLUT1-IR was seen only in the external cuneate nucleus and spinocerebellar tract region of the ventral medulla. In the cerebellum, P2X(7)R-IR co-localised with both VGLUT1 and VGLUT2-IR in the granular layer. In the hippocampus it was co-localised only with VGLUT1-IR, including in the polymorphic layer of the dentate gyrus and the substantia radiatum of the CA3 region. In other forebrain areas, P2X(7)R-IR co-localised with VGLUT1-IR throughout the amygdala, caudate putamen, striatum, reticular thalamic nucleus and cortex and with VGLUT2-IR in the dorsal lateral geniculate nucleus, amygdala and hypothalamus. Dual labelling studies performed using markers for cholinergic, monoaminergic, GABAergic and glycinergic terminals indicated that in certain brainstem and spinal cord nuclei the P2X(7)R is also expressed by subpopulations of cholinergic and GABAergic/glycinergic terminals. These data support our previous hypothesis that the P2X(7)R may play a role in modulating glutamate release in functionally different systems throughout the CNS but further suggest a role in modulating release of inhibitory transmitters in some regions.


Subject(s)
Brain/metabolism , Carrier Proteins/analysis , Membrane Transport Proteins , Receptors, Purinergic P2/analysis , Spinal Cord/metabolism , Vesicular Transport Proteins , Animals , Brain Chemistry/physiology , Carrier Proteins/biosynthesis , Presynaptic Terminals , Rats , Rats, Wistar , Receptors, Purinergic P2/biosynthesis , Receptors, Purinergic P2X7 , Spinal Cord/chemistry , Vesicular Glutamate Transport Protein 1 , Vesicular Glutamate Transport Protein 2
10.
Mol Cell Neurosci ; 24(1): 214-23, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14550781

ABSTRACT

GABA(B) receptor subunits are widely expressed on neurons throughout the CNS, at both pre- and postsynaptic sites, where they mediate the late, slow component of the inhibitory response to the major inhibitory neurotransmitter GABA. The existence of functional GABA(B) receptors on nonneuronal cells has been reported previously, although the molecular composition of these receptors has not yet been described. Here we demonstrate for the first time, using immunohistochemistry the expression of GABA(B1a), GABA(B1b), and GABA(B2) on nonneuronal cells of the rat CNS. All three principle GABA(B) receptor subunits were expressed on these cells irrespective of whether they had been cultured or found within brain tissue sections. At the ultrastructural level GABA(B) receptor subunits were expressed on astrocytic processes surrounding both symmetrical and assymetrical synapses in the CA1 subregion of the hippocampus. In addition, GABA(B1a), GABA(B1b), and GABA(B2) receptor subunits were expressed on activated microglia in culture but were not found on myelin forming oligodendrocytes in the white matter of rat spinal cord. Together these data demonstrate that the obligate subunits of functional GABA(B) receptors are expressed in astrocytes and microglia in the rat CNS.


Subject(s)
Astrocytes/metabolism , Brain/metabolism , Microglia/metabolism , Receptors, GABA-B/biosynthesis , Animals , Astrocytes/ultrastructure , Brain/ultrastructure , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Cells, Cultured , Immunohistochemistry , Male , Microglia/ultrastructure , Microscopy, Electron , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Protein Subunits/biosynthesis , Rats , Rats, Sprague-Dawley , Synaptic Transmission/physiology , gamma-Aminobutyric Acid/metabolism
11.
Neuroscience ; 118(1): 115-22, 2003.
Article in English | MEDLINE | ID: mdl-12676143

ABSTRACT

In the nucleus of the solitary tract (NTS), nitric oxide (NO) modulates neuronal circuits controlling autonomic functions. A proposed source of this NO is via nitric oxide synthase (NOS) present in vagal afferent fibre terminals, which convey visceral afferent information to the NTS. Here, we first determined with electron microscopy that neuronal NOS (nNOS) is present in both presynaptic and postsynaptic structures in the NTS. To examine the relationship of nNOS to vagal afferent fibres the anterograde tracer biotinylated dextran amine was injected into the nodose ganglion and detected in brainstem sections using peroxidase-based methods. nNOS was subsequently visualised using a pre-embedding immunogold procedure. Ultrastructural examination revealed nNOS immunoreactivity in dendrites receiving vagal afferent input. However, although nNOS-immunoreactive terminals were frequently evident in the NTS, none were vagal afferent in origin. Dual immunofluorescence also confirmed lack of co-localisation. Nevertheless, nNOS immunoreactivity was observed in vagal afferent neurone cell bodies of the nodose ganglion. To determine if these labelled cells in the nodose ganglion were indeed vagal afferent neurones nodose ganglion sections were immunostained following application of cholera toxin B subunit to the heart. Whilst some cardiac-innervating neurones were also nNOS immunoreactive, nNOS was never detected in the central terminals of these neurones. These data show that nNOS is present in the NTS in both pre- and postsynaptic structures. However, these presynaptic structures are unlikely to be of vagal afferent origin. The lack of nNOS in vagal afferent terminals in the NTS, yet the presence in some vagal afferent cell bodies, suggests it is selectively targeted to specific regions of the same neurones.


Subject(s)
Nitrergic Neurons/metabolism , Nitric Oxide Synthase/metabolism , Nitric Oxide/metabolism , Presynaptic Terminals/metabolism , Solitary Nucleus/metabolism , Vagus Nerve/metabolism , Visceral Afferents/metabolism , Animals , Cell Compartmentation/physiology , Cholera Toxin/metabolism , Dendrites/metabolism , Dendrites/ultrastructure , Heart/innervation , Heart/physiology , Immunohistochemistry , Male , Microscopy, Electron , Neurons, Afferent/metabolism , Neurons, Afferent/ultrastructure , Nitrergic Neurons/ultrastructure , Nodose Ganglion/metabolism , Nodose Ganglion/ultrastructure , Rats , Rats, Wistar , Solitary Nucleus/ultrastructure , Synaptic Membranes/metabolism , Synaptic Membranes/ultrastructure , Vagus Nerve/ultrastructure , Visceral Afferents/ultrastructure
13.
J Neurosci ; 21(18): 7143-52, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11549725

ABSTRACT

The ionotropic ATP receptor subunits P2X(1-6) receptors play important roles in synaptic transmission, yet the P2X(7) receptor has been reported as absent from neurons in the normal adult brain. Here we use RT-PCR to demonstrate that transcripts for the P2X(7) receptor are present in extracts from the medulla oblongata, spinal cord, and nodose ganglion. Using in situ hybridization mRNA encoding, the P2X(7) receptor was detected in numerous neurons throughout the medulla oblongata and spinal cord. Localizing the P2X(7) receptor protein with immunohistochemistry and electron microscopy revealed that it is targeted to presynaptic terminals in the CNS. Anterograde labeling of vagal afferent terminals before immunohistochemistry confirmed the presence of the receptor in excitatory terminals. Pharmacological activation of the receptor in spinal cord slices by addition of 2'- and 3'-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate (BzATP; 30 microm) resulted in glutamate mediated excitation of recorded neurons, blocked by P2X(7) receptor antagonists oxidized ATP (100 microm) and Brilliant Blue G (2 microm). At the neuromuscular junction (NMJ) immunohistochemistry revealed that the P2X(7) receptor was present in motor nerve terminals. Furthermore, motor nerve terminals loaded with the vital dye FM1-43 in isolated NMJ preparations destained after application of BzATP (30 microm). This BzATP evoked destaining is blocked by oxidized ATP (100 microm) and Brilliant Blue G (1 microm). This indicates that activation of the P2X(7) receptor promotes release of vesicular contents from presynaptic terminals. Such a widespread distribution and functional role suggests that the receptor may be involved in the fundamental regulation of synaptic transmission at the presynaptic site.


Subject(s)
Central Nervous System/metabolism , Neurons/metabolism , Peripheral Nervous System/metabolism , Presynaptic Terminals/metabolism , Receptors, Purinergic P2/metabolism , Animals , Central Nervous System/chemistry , Central Nervous System/cytology , Glutamic Acid/metabolism , Immunohistochemistry , In Situ Hybridization , Male , Medulla Oblongata/chemistry , Medulla Oblongata/cytology , Medulla Oblongata/metabolism , Mice , Mice, Inbred C57BL , Muscle, Skeletal/innervation , Neuromuscular Junction/metabolism , Neurons/cytology , Neurotransmitter Agents/metabolism , Nodose Ganglion/chemistry , Nodose Ganglion/cytology , Nodose Ganglion/metabolism , Patch-Clamp Techniques , Peripheral Nervous System/chemistry , Peripheral Nervous System/cytology , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , Rats , Rats, Wistar , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X7 , Reverse Transcriptase Polymerase Chain Reaction , Spinal Cord/chemistry , Spinal Cord/cytology , Spinal Cord/metabolism , Synaptic Transmission/physiology
14.
Neuroscience ; 106(2): 433-46, 2001.
Article in English | MEDLINE | ID: mdl-11566512

ABSTRACT

Sympathetic preganglionic neurones located in the intermediolateral cell column (IML) are subject to inputs descending from higher brain regions, as well as strong influences from local interneurones. Since interneurones in the IML have been rarely studied directly we examined their electrophysiological and anatomical properties. Whole cell patch clamp recordings were made from neurones in the IML of 250 microM slices of the thoracic spinal cord of the rat at room temperature. Action potential durations of interneurones (4.2+/-0.1 ms) were strikingly shorter than those of sympathetic preganglionic neurones (9.4+/-0.2 ms) due to a more rapid repolarisation phase. Low concentrations of tetraethylammonium chloride (TEA) (0.5 mM) or 4-aminopyridine (4-AP) (30 microM) affected interneurones but not sympathetic preganglionic neurones by prolonging the action potential repolarisation as well as decreasing both the afterhypolarisation amplitude and firing frequency. Following recordings, neurones sensitive to TEA and 4-AP were confirmed histologically as interneurones with axons that ramified extensively in the spinal cord, including the IML and other autonomic regions. In contrast, all cells that were insensitive to TEA and 4-AP were confirmed as sympathetic preganglionic neurones. Both electrophysiological and morphological data are therefore consistent with the presence of the voltage-gated potassium channel subunit Kv3.1 in interneurones, but not sympathetic preganglionic neurones. Testing this proposal immunohistochemically revealed that Kv3.1b was localised in low numbers of neurones within the IML but in higher numbers of neurones on the periphery of the IML. Kv3.1b-expressing neurones were not sympathetic preganglionic neurones since they were not retrogradely labelled following intraperitoneal injections of Fluorogold. Since Kv3.2 plays a similar role to Kv3.1 we also tested for the presence of Kv3.2 using immunohistochemistry, but failed to detect it in neuronal somata in the spinal cord. These studies provide electrophysiological and morphological data on interneurones in the IML and indicate that the channels containing the Kv3.1 subunit are important in setting the firing pattern of these neurones.


Subject(s)
Action Potentials/physiology , Interneurons/metabolism , Neuropeptides/metabolism , Potassium Channels, Voltage-Gated , Potassium Channels/metabolism , Spinal Cord/metabolism , Stilbamidines , Sympathetic Nervous System/metabolism , 4-Aminopyridine/pharmacology , Action Potentials/drug effects , Animals , Axons/drug effects , Axons/metabolism , Axons/ultrastructure , Cell Size/physiology , Dendrites/drug effects , Dendrites/metabolism , Dendrites/ultrastructure , Fluorescent Dyes/pharmacokinetics , Immunohistochemistry , Interneurons/cytology , Interneurons/drug effects , Molecular Probes/pharmacokinetics , Neuropeptides/antagonists & inhibitors , Patch-Clamp Techniques , Potassium Channel Blockers , Rats , Shaw Potassium Channels , Spinal Cord/cytology , Spinal Cord/drug effects , Sympathetic Nervous System/cytology , Sympathetic Nervous System/drug effects , Tetraethylammonium/pharmacology , Thoracic Vertebrae
15.
J Neurosci ; 21(16): 6308-20, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11487654

ABSTRACT

Although adenosine is an important neuromodulator in the CNS, its role in modulating sympathetic outflow at the level of the spinal cord has not been studied. Because very little is known about adenosine A1 receptors (A1Rs) in the spinal cord, we determined their location and role with particular reference to the control of sympathetic preganglionic activity and interneuronal activity in the rat. High levels of immunoreactivity for A1Rs were observed throughout the spinal cord. Immunostaining was dense in the intermediolateral cell column (IML) and intercalated nucleus, regions containing retrogradely labeled sympathetic preganglionic neurons (SPNs). Electron microscopy revealed A1R immunoreactivity (A1R-IR) within presynaptic terminals and (to a lesser extent) postsynaptic structures in the IML, as well as the luminal membrane of endothelial cells lining capillaries. Using double-labeling techniques, some presynaptic terminals were observed to synapse onto SPNs. To investigate the effects of activating these A1Rs, visualized whole-cell patch-clamp recordings were made from electrophysiologically and morphologically identified SPNs and interneurons. Applications of the A1R agonist cyclopentyladenosine (CPA) reduced the amplitude of EPSPs elicited by stimulation of the lateral funiculus, an effect blocked by the A1R antagonist 8-cyclopentyl-1,3-dipropylxanthine. These effects were attributable to adenosine acting at a presynaptic site because CPA application increased the paired-pulse ratio. CPA did not affect evoked IPSPs. These data show that activating A1Rs reduces fast excitatory, but not inhibitory, transmission onto SPNs and interneurons in the IML and that A1Rs may play a protective role on neurons involved in the control of sympathetic outflow.


Subject(s)
Neural Inhibition/physiology , Receptors, Purinergic P1/metabolism , Sympathetic Nervous System/cytology , Sympathetic Nervous System/metabolism , Synapses/metabolism , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , Antibody Specificity , Electric Stimulation , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Immunohistochemistry , In Vitro Techniques , Interneurons/cytology , Interneurons/drug effects , Interneurons/metabolism , Male , Microscopy, Electron , Patch-Clamp Techniques , Purinergic P1 Receptor Agonists , Purinergic P1 Receptor Antagonists , Rats , Reaction Time/physiology , Spinal Cord/cytology , Spinal Cord/drug effects , Spinal Cord/metabolism , Sympathetic Nervous System/drug effects , Synapses/ultrastructure , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Thorax , Xanthines/pharmacology
16.
Neuroscience ; 105(1): 231-48, 2001.
Article in English | MEDLINE | ID: mdl-11483315

ABSTRACT

Despite the highly integrated pattern of response evoked by peripheral chemoreceptor stimulation, limited information exists regarding the neurones within the nucleus of the solitary tract that mediate this reflex. Using a working heart-brainstem preparation, we describe evoked synaptic response patterns, some intrinsic membrane properties, location, morphology and axonal projections of physiologically characterised 'chemoreceptive' neurones located in the solitary tract nucleus in the rat. From 172 whole cell recordings, 56 neurones were identified as chemoreceptive since they responded to aortic injections of low doses of sodium cyanide (2-5 microg). Chemoreceptive neurones had a mean resting membrane potential of -52+/-1 mV and input resistance was 297+/-15 M(Omega) (n=56). Synaptic responses evoked included excitatory synaptic potentials alone, excitatory-inhibitory post-synaptic potential complexes, inhibitory synaptic potentials alone and central respiratory modulated synaptic potentials. Synaptic response latency data were obtained by stimulating electrically the solitary tract: the mean excitatory synaptic latency was 5.2+/-0.4 ms (range 2.5-8.0 ms; n=17). Chemoreceptive neurones showed a heterogeneity in their intrinsic membrane properties: neurones displayed either steady state, augmenting or adapting firing responses to depolarising current injection and, in some neurones, either delayed excitation or rebound activity following hyperpolarising pulses. Eleven chemoreceptive neurones were labelled and provided the first morphological data of these cells. Labelled somata were detected dorsomedial or medial to the solitary tract spanning the obex. Neurones typically had three to eight primary dendrites which often entered the solitary tract as well as extending across the ipsilateral region of the nucleus of the solitary tract. Axons were mostly unmyelinated with boutons of the en passant variety and often ramified within the solitary tract nucleus as well as coursed towards the ipsilateral ventral medulla. In summary, this study provides new data on the neurophysiological, anatomical and morphological properties of nucleus of the solitary tract neurones responding to arterial chemoreceptors in the rat.


Subject(s)
Action Potentials/physiology , Chemoreceptor Cells/cytology , Neurons/cytology , Solitary Nucleus/cytology , Action Potentials/drug effects , Afferent Pathways/physiology , Animals , Axons/ultrastructure , Carotid Body/drug effects , Carotid Body/physiology , Cell Size/drug effects , Cell Size/physiology , Chemoreceptor Cells/drug effects , Chemoreceptor Cells/physiology , Dendrites/ultrastructure , Electric Stimulation , Esophagus/innervation , Esophagus/physiology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Immunohistochemistry , Male , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neurons/drug effects , Neurons/physiology , Pressoreceptors/physiology , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Reaction Time/physiology , Respiratory Physiological Phenomena/drug effects , Sodium Cyanide/pharmacology , Solitary Nucleus/drug effects , Solitary Nucleus/physiology , Synapses/physiology , Vagus Nerve/physiology
17.
J Physiol ; 531(Pt 2): 445-58, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11230517

ABSTRACT

Angiotensin II (ANGII) acting on ANGII type 1 (AT1) receptors in the solitary tract nucleus (NTS) depresses the baroreflex. Since ANGII stimulates the release of nitric oxide (NO), we tested whether the ANGII-mediated depression of the baroreflex in the NTS depended on NO release. In a working heart-brainstem preparation (WHBP) of rat NTS microinjection of either ANGII (500 fmol) or a NO donor (diethylamine nonoate, 500 pmol) both depressed baroreflex gain by -56 and -67 %, respectively (P < 0.01). In contrast, whilst ANGII potentiated the peripheral chemoreflex, the NO donor was without effect. NTS microinjection of non-selective NO synthase (NOS) inhibitors (L-NAME; 50 pmol) or (L-NMMA; 200 pmol) prevented the ANGII-induced baroreflex attenuation (P > 0.1). In contrast, a neurone-specific NOS inhibitor, TRIM (50 pmol), was without effect. Using an adenoviral vector, a dominant negative mutant of endothelial NOS (TeNOS) was expressed bilaterally in the NTS. Expression of TeNOS affected neither baseline cardiovascular parameters nor baroreflex sensitivity. However, ANGII microinjected into the transfected region failed to affect the baroreflex.Immunostaining revealed that eNOS-positive neurones were more numerous than those labelled for AT1 receptors. Neurones double labelled for both AT1 receptors and eNOS comprised 23 +/- 5.4 % of the eNOS-positive cells and 57 +/- 9.2 % of the AT1 receptor-positive cells. Endothelial cells were also double labelled for eNOS and AT1 receptors. We suggest that ANGII activates eNOS located in either neurones and/or endothelial cells to release NO, which acts selectively to depress the baroreflex.


Subject(s)
Angiotensin II/pharmacology , Baroreflex/physiology , Coronary Vessels/physiology , Nitric Oxide Synthase/physiology , Adenoviridae/genetics , Animals , Baroreflex/drug effects , Enzyme Inhibitors/pharmacology , Genes, Dominant , Genetic Vectors , Heart/physiology , Immunohistochemistry , Male , Nitric Oxide/metabolism , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type III , Prodrugs/pharmacology , Rats , Rats, Wistar , Respiratory Physiological Phenomena , Solitary Nucleus/drug effects , Solitary Nucleus/enzymology , Solitary Nucleus/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...